Related Experiment Video
Updated: Aug 1, 2025

05:37
Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
Published on: April 4, 2025
774
Coronavirus genomic cDNA derived G-quadruplex as a selective target for fluorometric detection
Sumon Pratihar1, Mohamed Nabeel Mattath1, Thimmaiah Govindaraju1
1Bioorganic Chemistry Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Jakkur, P.O., Bengaluru, 560064, Karnataka, India. tgraju@jncasr.ac.in.
Summary
G-quadruplex (GQ) forming sequences in pathogenic genomes like SARS-CoV-2 are identified as diagnostic targets. Small molecular probes enable high-fidelity fluorescence detection of these specific SARS-CoV-2 cDNA GQs for reliable diagnosis.
Area of Science:
- Genomics
- Molecular Biology
- Diagnostic Development
Background:
- Pathogenic genomes can contain noncanonical G-quadruplex (GQ) forming sequences.
- These GQ-forming sequences represent potential targets for disease diagnosis.
Purpose of the Study:
- To identify and validate G-quadruplex (GQ) forming cDNA sequences within the SARS-CoV-2 (Severe acute respiratory syndrome coronavirus-2) genome.
- To demonstrate the utility of these sequences as reliable diagnostic targets.
Main Methods:
- Bioinformatic identification of potential GQ-forming sequences in the SARS-CoV-2 genome.
- Experimental validation of identified cDNA GQs.
- Development and application of small molecular probes for fluorescence detection.
Main Results:
- GQ-forming cDNA sequences specific to SARS-CoV-2 were identified and validated.
- High-fidelity fluorescence detection of these SARS-CoV-2 derived cDNA GQs was achieved.
- Demonstrated the potential of these probes for accurate detection.
Conclusions:
- SARS-CoV-2 cDNA GQs are validated as reliable targets for molecular diagnostics.
- Small molecular probes offer a sensitive and specific method for detecting these diagnostic targets.
- This approach holds promise for the development of novel diagnostic tools for SARS-CoV-2.

